Masters Capital Management LLC Gilead Sciences, Inc. Transaction History

Masters Capital Management LLC

$2 Billion
Q3 2024

A detailed history of Masters Capital Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Masters Capital Management LLC holds 1,000,000 shares of GILD stock, worth $92.4 Million. This represents 4.19% of its overall portfolio holdings.

Number of Shares

1,000,000

Previous 385,000 159.74%

Holding current value

$92.4 Million

Previous $26.4 Million 217.33%

% of portfolio

4.19%

Previous 1.52%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $27.1 Million - $29.2 Million	-400,000 Reduced 40.0%	600,000 $41.9 Million
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $60 Million - $68.5 Million	1,000,000 New	1,000,000 $64.6 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $18.6 Million - $20.8 Million	-300,000 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $18.8 Million - $21 Million	300,000 New	300,000 $19.5 Million
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $6.05 Million - $7.9 Million	-100,000 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $20.2 Million - $22.4 Million	-283,780 Reduced 73.94%	100,000 $7.72 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $11.9 Million - $13.9 Million	183,780 Added 91.89%	383,780 $27.2 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $7.28 Million - $8.88 Million	-100,000 Reduced 33.33%	200,000 $15.1 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $21.3 Million - $25.1 Million	300,000	300,000 $21.5 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Masters Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Masters Capital Management LLC with notifications on news.

Account

Masters Capital Management LLC Gilead Sciences, Inc. Transaction History